Cargando…

Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study

Forced degradation study is a systemic characterization of degradation products of active pharmaceutical ingredient (API) at conditions which posses more harsh environment that accelerates degradation of API. Forced degradation and stability studies would be useful in selection of proper, packaging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sojitra, Chandrakant, Dholakia, Chintan, Sudhakar, Padmaja, Singh, Kumar K., Agarwal, Sameer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144688/ https://www.ncbi.nlm.nih.gov/pubmed/34056545 http://dx.doi.org/10.1007/s42452-021-04660-y

Ejemplares similares

Forced Degradation Behaviour of Fluphenazine Hydrochloride by LC and Characterization of its Oxidative Degradation Product by LC–MS/MS
por: Thummar, Kashyap N., et al.
Publicado: (2015)

Identification of Forced Degradation Products of Itopride by LC-PDA and LC-MS
por: Joshi, Payal, et al.
Publicado: (2011)

Characterization of forced degradation products of toloxatone by LC-ESI-MS/MS
por: Skibiński, Robert, et al.
Publicado: (2018)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol
por: Rakibe, Uday, et al.
Publicado: (2018)

Study of forced degradation behavior of pramlintide acetate by HPLC and LC–MS
por: Yuan, Yu, et al.
Publicado: (2017)

Characterization of the Oxidative Degradation Product of Darunavir by LC-MS/MS
por: Yamjala, Karthik, et al.
Publicado: (2015)

LC–UV and LC–MS evaluation of stress degradation behavior of desvenlafaxine
por: Pawar, Shubhangi M., et al.
Publicado: (2012)

Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
por: Li, Jin, et al.
Publicado: (2014)

Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C
por: Vemuri, Divya Kumar, et al.
Publicado: (2022)

Multivariate Chemometric Comparison of Forced Degradation and Electrochemical Oxidation LC–MS Profiles of Maraviroc
por: Wroński, Michał, et al.
Publicado: (2023)

The LC-QTOF-MS/MS analysis of acid degradation products of Rifaximin, an antibiotic
por: Yaseen, Saima Baig, et al.
Publicado: (2022)

Development and Validation of LC-MS/MS for Analyzing Potential Genotoxic Impurities in Pantoprazole Starting Materials
por: Chen, Yuyuan, et al.
Publicado: (2020)

Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF
por: Gawande, V. T., et al.
Publicado: (2015)

Structural Elucidation of Alkali Degradation Impurities of Favipiravir from the Oral Suspension: UPLC-TQ-ESI-MS/MS and NMR
por: Patel, Ravi, et al.
Publicado: (2022)

Quantification of Degradation Products Formed during Heat Sterilization of Glucose Solutions by LC-MS/MS: Impact of Autoclaving Temperature and Duration on Degradation
por: Leitzen, Sarah, et al.
Publicado: (2021)

Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation Products
por: Vukkum, Pallavi, et al.
Publicado: (2013)

Selective separation, detection of zotepine and mass spectral characterization of degradants by LC–MS/MS/QTOF
por: Talluri, M.V.N. Kumar, et al.
Publicado: (2014)

Identification of the Impurities in Bopu Powder(®) and Sangrovit(®) by LC-MS Combined with a Screening Method
por: Dong, Zhuang, et al.
Publicado: (2021)

Research on the Trajectory Model for ZY-3
por: Chen, Yifu, et al.
Publicado: (2014)

Forced Degradation Studies of Ivabradine and In Silico Toxicology Predictions for Its New Designated Impurities
por: Pikul, Piotr, et al.
Publicado: (2016)

Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method
por: Sudhakar Babu, Kondru, et al.
Publicado: (2012)

Kinetics and Characterization of Degradation Products of Dihydralazine and Hydrochlorothiazide in Binary Mixture by HPLC-UV, LC-DAD and LC–MS Methods
por: Gumieniczek, Anna, et al.
Publicado: (2018)

Degradation Dynamics and Residue Analysis of Four Propiconazole Stereoisomers in “Fengtang” Plum during Storage by LC-MS/MS
por: Deng, Pengyu, et al.
Publicado: (2023)

HPLC Method for Simultaneous Determination of Impurities and Degradation Products in Zonisamide
por: Vijayakumar, E. K. S., et al.
Publicado: (2009)

Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance
por: Sivakumar, Balasubramanian, et al.
Publicado: (2013)

Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation
por: Karthik, Yamjala, et al.
Publicado: (2015)

TGR5 agonists induce peripheral and central hypersensitivity to bladder distension
por: Caldwell, Ashlee, et al.
Publicado: (2022)

Simultaneous Determination of 15 Sulfonate Ester Impurities in Phentolamine Mesylate, Amlodipine Besylate, and Tosufloxacin Tosylate by LC-APCI-MS/MS
por: Jin, Bo, et al.
Publicado: (2019)

Simultaneous detection of lysine metabolites by a single LC–MS/MS method: monitoring lysine degradation in mouse plasma
por: Pena, Izabella A., et al.
Publicado: (2016)

Identification, Isolation, and Characterization of a New Degradation Impurity in Nafcillin Sodium
por: Vundavilli, Jagadeesh Kumar, et al.
Publicado: (2015)

Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF
por: CAN, Nafiz Öncü
Publicado: (2018)

Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liquid chromatography mass spectrometry (LC–MS) based metabolomics
por: Lei, Yangyang, et al.
Publicado: (2022)

Green adherent degradation kinetics study of Nirmatrelvir, an oral anti-COVID-19: characterization of degradation products using LC–MS with insilico toxicity profile
por: Aboras, Sara I., et al.
Publicado: (2023)

A validated ultra high-pressure liquid chromatography method for separation of candesartan cilexetil impurities and its degradents in drug product
por: Kumar, Namala Durga Atchuta, et al.
Publicado: (2012)

Low Level Determinations of Methyl Methanesulfonate and Ethyl Methanesulfonate Impurities in Emtricitabine Active Pharmaceutical Ingredient by LC/MS/MS Using Electrospray Ionization
por: Kakadiya, P.R., et al.
Publicado: (2011)

Separation and Characterization of Novel Degradation and Process Related Impurities of Bedaquiline Bulk Drug
por: Vanavi, Pragati J, et al.
Publicado: (2021)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad, Shitalkumar P, et al.
Publicado: (2013)

The influence of effective microorganisms (EM) and yeast on the degradation of strobilurins and carboxamides in leafy vegetables monitored by LC-MS/MS and health risk assessment
por: Wołejko, Elżbieta, et al.
Publicado: (2015)

A stability-indicating LC–MS/MS method for zidovudine: Identification, characterization and toxicity prediction of two major acid degradation products
por: Devrukhakar, Prashant S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sgls1bui807k674eb7pndh8kcp